Microbot Medical Inc. (MBOT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US59503A2042
Microbot Medical Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -14.74 m USD |
| EBIT | -13.14 m USD |
| Net income | -13.14 m USD |
| Diluted EPS – continuing operations | -0.29 USD |
Full history since 1991, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
More stocks
- Lexibook Linguistic Electronic System SA (ALLEX.PA)
- Ezwelfare Co Ltd (090850.KQ)
- Cameo Communications Inc (6142.TW)
- AurosTechnology Inc. (322310.KQ)
- Asarian Energy Limited (ARN.TO)
- Cell Biotech Co. Ltd (049960.KQ)
- ACRES Commercial Realty Corp. (ACR)
- VivoPower PLC (VIVO)
- Groundhog Inc. (6906.TW)
- Bangkok Lab & Cosmetic PCL (BLC.BK)
- Marisa Lojas S.A (AMAR3.SA)
- Shih Kuen Plastics Co Ltd (4305.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.